Evolus (EOLS) Treasury Shares (2018 - 2025)
Evolus (EOLS) posted Treasury Shares of $568775.0 for Q4 2025, down 10.22% on a QoQ basis from $633536.0 in Q2 2025, and up 43.64% year-over-year from $395984.0 in Q4 2024.
Evolus (EOLS) Treasury Shares (2018 - 2025) Analysis & Trends
Evolus' Treasury Shares history runs 8 years deep, the most recent figure standing at $568775.0 for Q4 2025.
- Quarterly Treasury Shares rose 43.64% year-over-year to $568775.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $568775.0 (up 43.64% YoY) and the FY2025 annual result came in at $568775.0, up 43.64% from the prior year.
- Treasury Shares was $568775.0 for Q4 2025 at Evolus, down from $633536.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $3.3 million in Q3 2023 and bottomed at $233880.0 in Q4 2023.
- A 5-year average of $1.8 million and a median of $2.1 million in 2021 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2021 — Treasury Shares soared 339.04% — and 2023, when it tumbled 91.33%.
- Evolus' Treasury Shares stood at $1.9 million in 2021, then soared by 39.97% to $2.7 million in 2022, then tumbled by 91.33% to $233880.0 in 2023, then jumped by 69.31% to $395984.0 in 2024, then jumped by 43.64% to $568775.0 in 2025.
- Business Quant data shows EOLS's Treasury Shares at $568775.0 in Q4 2025, $633536.0 in Q2 2025, and $749647.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 568,775.00 |
| Dec 31, 2025 | 568,775.00 |
| Jun 30, 2025 | 633,536.00 |
| Jun 30, 2025 | 633,536.00 |
| Mar 31, 2025 | 749,647.00 |
| Mar 31, 2025 | 749,647.00 |
| Dec 31, 2024 | 395,984.00 |
| Dec 31, 2024 | 395,984.00 |
| Sep 30, 2024 | 355,914.00 |
| Sep 30, 2024 | 355,914.00 |
| Jun 30, 2024 | 355,914.00 |
| Jun 30, 2024 | 355,914.00 |
| Mar 31, 2024 | 3.29 Mn |
| Mar 31, 2024 | 3.29 Mn |
| Dec 31, 2023 | 233,880.00 |
| Dec 31, 2023 | 233,880.00 |
| Sep 30, 2023 | 3.29 Mn |
| Sep 30, 2023 | 3.29 Mn |
| Jun 30, 2023 | 3.21 Mn |
| Jun 30, 2023 | 3.21 Mn |